0000950170-24-131200.txt : 20241126 0000950170-24-131200.hdr.sgml : 20241126 20241126192532 ACCESSION NUMBER: 0000950170-24-131200 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241122 FILED AS OF DATE: 20241126 DATE AS OF CHANGE: 20241126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Goldshleger Ilya CENTRAL INDEX KEY: 0001874147 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40690 FILM NUMBER: 241505916 MAIL ADDRESS: STREET 1: C/O RXSIGHT, INC. STREET 2: 100 COLUMBIA CITY: ALISO VIEJO STATE: CA ZIP: 92656 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RxSight, Inc. CENTRAL INDEX KEY: 0001111485 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 943268801 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 COLUMBIA STREET STREET 2: SUITE 120 CITY: ALISO VIEJO STATE: CA ZIP: 92656 BUSINESS PHONE: 949-521-7822 MAIL ADDRESS: STREET 1: 100 COLUMBIA STREET STREET 2: SUITE 120 CITY: ALISO VIEJO STATE: CA ZIP: 92656 FORMER COMPANY: FORMER CONFORMED NAME: CALHOUN VISION INC DATE OF NAME CHANGE: 20000410 4 1 ownership.xml 4 X0508 4 2024-11-22 0001111485 RxSight, Inc. RXST 0001874147 Goldshleger Ilya C/O RXSIGHT, INC. 100 COLUMBIA ALISO VIEJO CA 92656 false true false false See remarks true Common Stock 2024-11-22 4 M false 3100 15.08 A 45346 D Common Stock 2024-11-22 4 S false 3100 45 D 42246 D Common Stock 2024-11-26 4 M false 3100 15.08 A 45346 D Common Stock 2024-11-26 4 S false 3100 45.88 D 42246 D Common Stock 1372 I By spouse Stock Option (right to buy) 15.08 2024-11-22 4 M false 3100 0.00 D 2030-04-22 Common Stock 3100 46982 D Stock Option (right to buy) 15.08 2024-11-26 4 M false 3100 0.00 D 2030-04-22 Common Stock 3100 43882 D The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on June 3, 2024 by the Reporting Person. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan, as amended) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean April 23, 2020. Co-President and Chief Operating Officer /s/ Shelley Thunen, as Attorney-in-Fact 2024-11-26